Jackie Fouse recruits an executive team and beefs up the dermatology pipeline at Dermavant
Jackie Fouse has assembled her executive team at Dermavant and bagged her 5th drug for a beefed up pipeline of skin therapies.
The biotech, part of Vivek Ramaswamy’s network of companies at Roivant, recruited GlaxoSmithKline’s dermatology R&D chief David Rubinstein as chief scientific officer. Rubinstein earlier had worked at Duke. Richard Peterson, formerly at Medicis, has joined as CFO. Ariel Jasie, former CBO at Codiak BioSciences, came on board in the same role, with Chris Van Tuyl joining as general counsel.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
